OpenLB
Open Library of Bioscience

Mitochondria Dysfunction and Chronic Fatigue Syndrome.

Abstract

No abstract text available.

References

1. Vahratian A, Lin JS, Bertolli J, Unger ER. Myalgic encephalomyelitis/chronic fatigue syndrome in adults: United States, 2021–2022. NCHS Data Brief, Vol. 488. Hyattsville, MD. National Center for Health Statistics; 2023.
2. Underhill RA. Myalgic encephalomyelitis, chronic fatigue syndrome: an infectious disease. Med Hypotheses. 2015;85(6):765–773. doi: 10.1016/j.mehy.2015.10.011. [DOI: 10.1016/j.mehy.2015.10.011]
3. Monro JA, Puri BK. A molecular neurobiological approach to understanding the aetiology of chronic fatigue syndrome (myalgic encephalomyelitis or systemic exertion intolerance disease) with treatment implications. Mol Neurobiol. 2018;55(9):7377–7388. doi: 10.1007/s12035-018-0928-9. [DOI: 10.1007/s12035-018-0928-9]
4. National Institutes of Health-National Institute of Neurological Disorders and Stroke. NIH Intramural Study on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Washington, DC. National Institutes of Health; 2016. https://www.nih.gov/mecfs/nih-intramural-mecfs-study. Accessed March 24, 2024.
5. Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2016;4(1):30. doi:10.1186/s40168-016-0171-4. [DOI: 10.1186/s40168-016-0171-4]
6. Rolfe DFS, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev. 1997; 77:731–758.
7. Annesley SJ, Fisher PR. Mitochondria in Health and Disease. Cells. 2019;8(7):x680. doi: 10.3390/cells8070680. [DOI: 10.3390/cells8070680]
8. San-Millan I. The key role of mitochondrial function in health and disease. Antioxidants. 2023;12(4):782. doi: 10.3390/antiox12040782. [DOI: 10.3390/antiox12040782]
9. Wallace DC. A mitochondrial bioenergetic etiology of disease. J Clin Investig. 2013;123(4):1405–1412. doi: 10.1172/JCI61398. [DOI: 10.1172/JCI61398]
10. Komaroff AL, Bateman L. Will COVID-19 Lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med. 2020;7:606824. doi:10.3389/fmed.2020.606824. [DOI: 10.3389/fmed.2020.606824]
11. Armstrong CW, McGregor NR, Butt HL, Gooley PR. Metabolism in chronic fatigue syndrome. Adv Clin Chem. 2014;66:121–172.
12. Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. 2000;5:93–108.
13. Saini R. Coenzyme Q10: The essential nutrient. J Pharm Bioallied Sci. 2011;3(3):466–467.doi: 10.4103/0975-7406.84471. [DOI: 10.4103/0975-7406.84471]
14. Marashly ET, Bohlega SA. Riboflavin has neuroprotective potential: focus on Parkinson’s disease and migraine. Front Neurol. 2017;8:333. doi:10.3389/fneur.2017.00333. [DOI: 10.3389/fneur.2017.00333]
15. Jonscher KR, Chowanadisai W, Rucker RB. Pyrroloquinoline-quinone is more than an antioxidant: a vitamin-like accessory factor important in health and disease prevention. Biomolecules. 2021;11(10):1441. doi:10.3390/biom11101441 [DOI: 10.3390/biom11101441]
16. Sekhar RV. GlyNAC (glycine and N-Acetylcysteine) supplementation improves impaired mitochondrial fuel oxidation and lowers insulin resistance in patients with type 2 diabetes: results of a pilot study. Antioxidants (Basel). 2022;11(1):154. doi: 10.3390/antiox11010154. [DOI: 10.3390/antiox11010154]
17. Hazim R, Paniagua A, Tang L, et al. Vitamin B3, nicotinamide, enhances mitochondrial metabolism to promote differentiation of the retinal pigment epithelium. J Biol Chem. 2022;298(9):102286. doi:10.1016/j.jbc.2022.102286. [DOI: 10.1016/j.jbc.2022.102286]

MeSH Term